- Report
- September 2026
- 194 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 271 Pages
Global
From €5271EUR$5,850USD£4,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- January 2026
- 182 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- October 2025
- 160 Pages
Global
From €2847EUR$3,160USD£2,442GBP
€3559EUR$3,950USD£3,052GBP
- Report
- January 2026
- 190 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- January 2026
- 314 Pages
Global
From €5250EUR$6,031USD£4,350GBP
- Report
- August 2026
- 248 Pages
Global
From €4324EUR$4,799USD£3,708GBP
- Report
- March 2026
- 248 Pages
Global
From €4324EUR$4,799USD£3,708GBP
- Report
- August 2026
- 440 Pages
Global
From €4460EUR$4,950USD£3,825GBP
- Report
- June 2026
- 200 Pages
Global
From €2694EUR$2,990USD£2,310GBP
- Report
- January 2026
- 150 Pages
Global
From €5361EUR$5,950USD£4,597GBP
- Report
- September 2026
- 188 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 198 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 199 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 196 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 184 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 196 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 195 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP
- Report
- September 2026
- 194 Pages
Global
From €3194EUR$3,545USD£2,739GBP
€3549EUR$3,939USD£3,044GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more